Article Details
Retrieved on: 2021-08-06 10:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The availability and global impact of first generation monoclonal antibodies (mAbs) has been very limited but more affordable and adapted second ...
Article found on: blogs.bmj.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here